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OUTCOME ASSESSMENT METHODOLOGY IN
CRITICAL LIMB ISCHAEMIA
Critical limb ischaemia represents a chronic reduction
in distal blood flow to the extent that viability of the
limb is threatened. Manifestations of this degree of
hypoperfusion include rest pain, nonhealing wounds
and ulcers, or ischaemic gangrene. Such a profound
reduction in peripheral blood flow is associated with
severe, diffuse atherosclerosis and increased likeli-
hood of death.
Despite aggressive correction of distal ischaemia,
these patients have a limited life expectancy, with less
than 60% surviving more than 3 years after treatment
1,2,3 (see A 2.7, Fate of Patients With CLI, P 521).
The therapeutic goals for the treatment of critical
limb ischaemia must reflect the clinical status of the
patient. An ideal treatment would improve both the
functional status of the leg and the life expectancy and
functional status of the patient. Unfortunately, such
interventions have not yet been developed.
Treatments must be directed both at the systemic
process, through control of risk factors, and at
improvement in distal perfusion. The extent to which
distal perfusion must be improved depends on the
general health and functional status of the patient and
the likelihood of successful improvement in these
states. The overall outcomes assessment of procedures
directed toward treatment of CLI must account for the
fragile status of this patient population.
Recommendation 80: Parameters for reporting suc-
cess of treatment for critical limb ischaemia
Success of treatment for critical limb ischaemia
should take into account an improvement in the
following:
Objective outcome: Complete healing of skin
lesions. Standardised reporting criteria should
include technical success, haemodynamic testing,
procedural morbidity, limb function, and amputa-
tion and mortality rates.
Symptomatic outcome: Relief of pain
• General quality of life: As assessed by a generic
health status instrument
• Post-revascularisation: Proof of patency of the
revascularised segment as defined in A 3.2.9,
Recommendation 5
D 3.1.1
Clinical Measures
Technical success
Technical success identifies the achievement of the
intended technical objective(s) of the complete proce-
dure. Although treatment of critical limb ischaemia
may require more than one treatment modality, for
example, thrombolytic therapy and bypass grafting,
technical success should be reported as successful
achievement of the desired result after all necessary
therapeutic procedures have been performed (see
Recommendation 51, p 5125). Technical success does
not require the restoration of palpable pedal pulses in
all cases. Many procedures, such as profundaplasty,
may provide increased distal perfusion through col-
lateral beds. Conversely, the technical inability to
carry out the intended therapeutic plan should be
reported as a technical failure. For example, the inabil-
ity to successfully lyse clot or construct a distal bypass
to a diminutive distal vessel constitutes a technical
failure.
(Repeatedfront p 5125)
Recommendation 51: Assessmellt of teellllical SIlC-
cess of multiple il/teroentiolls
Wllell' treatll~e1It inuolues multiple modalities, such
as thrombolytic tlzerapy and opel/ slirgenJ, "technical
success" should be reported as overall technical SIlC-
cess during the same hospitalisation period rather
than the success of each component of therapy,
although the success of each component of tlzerapy
also should be reported.
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Improvement ill «nkletbrachia! index
Successful revascularisation should lead to an increase
in ankle-brachial index (see A 3.2.4, Objective
Outcome Measures, p S33). In the setting of heavily
calcified distal vessels, it is appropriate to use toe pres-
sures or evaluation of pulse volume recordings or the
pole test! to determine haemodynamic success.
Arterial/graft patellcy
Appropriate follow-up studies to confirm patency of
the treated artery or bypass graft are reviewed in
Patency (A 3.2.9, P S37) and Surveillance After
Revascularisation, D 4.14, P S214). Primary patency
implies uninterrupted patency after performance of
the procedure(s). Assisted primary patency refers to
those patent arteries or grafts that have required addi-
tional intervention but have not thrombosed.
Secondary patency identifies those arteries or grafts
that have failed but were reopened by an additional
intervention.
Limbsalvage
Limb salvage after treatment for chronic critical limb
ischaemia (CLI) is defined as preservation of a func-
tional foot. Because patients with advanced CLI may
present with ischaemic gangrene of the toes, forefoot,
or heel, removal of this necrotic tissue is an essential
part of any therapeutic regimen. Loss of the toes, fore-
foot, and midfoot do not significantly alter the work of
ambulation and therefore may assist in the achieve-
ment of a functional limb. Amputation above the level
of the proximal forefoot constitutes failure of limb sal-
vage, whether or not revascularisation has been
accomplished.
Recommendation 81: Reporting limb salvage after
treatment of critical limb ischaemia
For reporting purposes, successful limb salvage
after treatment of critical limb ischaemia is defined
as the preservation of a functional limb, including
at least part of the foot, without requirement for a
prosthesis.
Healing of WOIIIIds
Complete healing refers to a continuous viable,
epithelial covering over all previously open wounds.
Eur J Vase Endovasc Surg Vol 19 Supplement A, June 2000
Long incisions are often required for surgical inter-
vention. Complete healing of wounds in patients
undergoing treatment of CLI must include the index
lesions present at the time therapy is initiated as well
as all surgical incisions required for patient treatment.
D 3.1.2
Effectiveness Measures
Short-term morbidity
Short-term morbidity of the treatment of patients with
CLI must include complications associated with major
diagnostic procedures and with therapeutic interven-
tions. Minor complications that do not necessitate
additional diagnostic tests, prolong hospitalisation or
recuperation, or require treatment need not be consid-
ered in the assessment of patient morbidity.
Procedural ntortalitsj
Procedural mortality is defined as death within 30
days of the intervention or within the same hospitali-
sation as the intervention, if this is longer than 30
days. Traditionally, the standard has been to report as
procedural mortality only those patients who die
within 30 days of therapy. Patients with CLI, however,
often have severe comorbid conditions that may be
worsened by the procedure. These in-hospital events,
such as myocardial infarction, respiratory failure, sep-
sis, and stroke, may be rapidly detected and treatment
undertaken that prevents immediate death, but ulti-
mately death ensues weeks or months later. Such
patients should be reported in the assessment of pro-
cedural mortality.
Symptomatic improuemeni
As described in A 3.2.5, Symptomatic Outcome
Measures, (p S34), symptomatic improvement can be
determined using one of the accepted classification
scales, such as the Fontaine or Rutherford scale.
Symptomatic improvement requires a movement
upward of at least one category without preexisting
tissue loss or two categories if pretreatment tissue loss
is present.
hnprooement ill quality of life
Currently, there are no quality-of-life instruments that
have been standardised in a large population of
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patients requiring treatment for CLI (see also Critical
Issue 2, p S34). The most commonly used generic
instrument. ithe SF-36 questionnaire, has been used by
some investigators in the evaluation of small groups
of patients to determine whether its scale appropriate-
ly reflects the benefits of successful treatment.
Functional status should be followed-up for at least 6
months postprocedure. Schneider and associates!
used the SF-20, similar to the SF-36, a derivative of the
Medical Outcomes Study, to evaluate 60 patients with
CLI. This group noted that those with CLI had signif-
icant decreases in functional health and well-being
despite successful revascularisation.
Duggan and colleagues- used the SF-36 question-
naire for the evaluation of 21 patients requiring treat-
ment for CLI. Interestingly, they noted no significant
difference in physical functioning between those
patients with patent and those with failed bypasses.
Additionally, the SF-36 did not indicate that patients
with functioning bypasses had better emotional and
general well-being scores . Chetter and associates? also
employed the SF-36 to evaluate 235 patients, 78 of
whom had CLI. They noted that the quality-of-life
scores obtained through the SF-36 deteriorated as dis-
tal perfusion worsened. Thus, although there has been
no broad standardisation of the SF-36 in patients with
CLI, it represents the most obvious option at the pres-
ent (see Recommendation 3, p S36).
Improvement in[unctional status
Improvement in functional status is often difficult to
define in patients with CLI because of the presence of
numerous and often severe comorbid conditions.
Simple assessment of walking distance, though use-
ful in some patients, does not apply to many. For
example, those patients who have had a previous
major amputation of the contralateral extremity may
have an improved ability to pivot and transfer from
bed to wheelchair after successful revascularisation
of the contralateral leg. This improvement would not
be detected by any current measures of functional
status. Therefore, specific instruments capable of
detecting improvement in functional status in this
diverse patient population must be developed.
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D 4.1
Overall Strategy for Treatment of Critical Limb
Ischaemia
Many of the principals of basic treatment discussed
in relation to patients with intermittent claudication
also apply to patients with CLI, although the urgency
for rapid treatment of the latter group will alter the
emphasis. For instance, the management of risk fac-
tors such as hyperlipidaemia is not of any immediate
importance in patients with CLI. By contrast, other
important aspects in the immediate basic treatment
of patients with CLI, such as adequate control of
pain, do not apply to claudication.
The principal urgent components of basic treat-
ment of CLI are the control of pain and any infection
in the ischaemic leg, prevention of progression of
thrombosis if this is thought to be a precipitating fac-
tor in the ischaemia, and the optimisation of cardiac
and respiratory function. While instituting basic
treatment, the full precise morphology of the PAD
should be simultaneously established by some form
of imaging technique. This will determine further
management of the arterial lesion. In a small group of
patients, often delayed referrals, ischaemia and gross
infection in the leg pose an immediate threat to the
patient's survival. An immediate major amputation
is mandatory and can be life saving in these cases, for
instance, in a patient with gas or septic gangrene.
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